Perspective Therapeutics Inc’s recently made public that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
Perspective Therapeutics Inc’s recently made public that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Perspective Therapeutics
Perspective Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
Perspective Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
In a filing, Perspective Therapeutics Inc revealed its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Perspective Therapeutics Inc’s recently made public that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Perspective Therapeutics Inc’s recently made public that its Chief Executive Officer Spoor Johan M. acquired Company’s shares for reported $49384.0